116 related articles for article (PubMed ID: 1397241)
1. Erythropoietin response in anaemic patients with multiple myeloma and other lymphoid malignancies infiltrating the bone marrow.
Ariad S; Clifford D; Penfold G; MacPhail AP; Bezwoda WR
Eur J Haematol; 1992 Aug; 49(2):59-62. PubMed ID: 1397241
[TBL] [Abstract][Full Text] [Related]
2. [Inadequate erythropoietin production (epo) in patients with multiple myeloma].
Kostova G; Siljanovski N
Prilozi; 2004; 25(1-2):53-66. PubMed ID: 15735535
[TBL] [Abstract][Full Text] [Related]
3. Blunted erythropoietin response to anaemia in rheumatoid arthritis.
Baer AN; Dessypris EN; Goldwasser E; Krantz SB
Br J Haematol; 1987 Aug; 66(4):559-64. PubMed ID: 3663512
[TBL] [Abstract][Full Text] [Related]
4. Serum erythropoietin and circulating BFU-E in patients with multiple myeloma and anaemia but without renal failure.
Majumdar G; Westwood NB; Bell-Witter C; Muggleston D; Phillips J; Pearson TC
Leuk Lymphoma; 1993 Jan; 9(1-2):173-6. PubMed ID: 8477197
[TBL] [Abstract][Full Text] [Related]
5. Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
Cazzola M; Beguin Y; Kloczko J; Spicka I; Coiffier B
Br J Haematol; 2003 Aug; 122(3):386-93. PubMed ID: 12877665
[TBL] [Abstract][Full Text] [Related]
6. The secretory erythropoietin response in patients with multiple myeloma and Waldenström's macroglobulinaemia.
Nielsen OJ; Brandt M; Drivsholm A
Scand J Clin Lab Invest; 1990 Nov; 50(7):697-703. PubMed ID: 2127316
[TBL] [Abstract][Full Text] [Related]
7. [Erythroid stem (CFU-E) cells and erythropoietin levels in certain hematological diseases].
Rokicka-Piotrowicz M; Paszkowska M; Kuratowska Z
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):276-9. PubMed ID: 7808951
[TBL] [Abstract][Full Text] [Related]
8. [Anemia and erythropoietin level in some hematology malignancies].
Rokicka-Piotrowicz M; Paszkowska M; Kuratowska Z
Pol Arch Med Wewn; 1994 Nov; 92(5):409-16. PubMed ID: 7885989
[TBL] [Abstract][Full Text] [Related]
9. [Erythropoietin activity of blood in anemia with hypoplastic and hyperplastic bone marrow].
Essers U; Mann H
Blut; 1971 Jun; 22(6):297-305. PubMed ID: 5559035
[No Abstract] [Full Text] [Related]
10. Erythropoietin/haemoglobin relationship in leukaemia and ulcerative colitis.
Johannsen H; Jelkmann W; Wiedemann G; Otte M; Wagner T
Eur J Haematol; 1989 Sep; 43(3):201-6. PubMed ID: 2806474
[TBL] [Abstract][Full Text] [Related]
11. Serum erythropoietin and reticulocyte counts in inflammatory process.
Souweine B; Serre AF; Philippe P; Conio N; Aumaitre O; Marcheix JC
Ann Med Interne (Paris); 1995; 146(1):8-12. PubMed ID: 7741403
[TBL] [Abstract][Full Text] [Related]
12. [Erythropoietin in the pathogenesis of anemia in patients with multiple myeloma].
Rokicka-Piotrowicz M; Paluszewska M; Paszkowska M; Rakowska A; Wierzbicka E; Buras A; Kuratowska Z
Pol Arch Med Wewn; 1998 Mar; 99(3):218-23. PubMed ID: 9760808
[TBL] [Abstract][Full Text] [Related]
13. Serum immunoreactive erythropoietin in health and disease.
Spivak JL
J Perinat Med; 1995; 23(1-2):13-7. PubMed ID: 7658313
[TBL] [Abstract][Full Text] [Related]
14. Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.
Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kontopidou FN; Pangalis GA
Leuk Lymphoma; 2000 Dec; 40(1-2):141-7. PubMed ID: 11426615
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M
Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.
Hedenus M; Adriansson M; San Miguel J; Kramer MH; Schipperus MR; Juvonen E; Taylor K; Belch A; Altés A; Martinelli G; Watson D; Matcham J; Rossi G; Littlewood TJ;
Br J Haematol; 2003 Aug; 122(3):394-403. PubMed ID: 12877666
[TBL] [Abstract][Full Text] [Related]
18. Serum erythropoietin levels in patients with solid tumours.
Kettelhack C; Schöter D; Matthias D; Schlag PM
Eur J Cancer; 1994; 30A(9):1289-91. PubMed ID: 7999415
[TBL] [Abstract][Full Text] [Related]
19. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
20. Testosterone, erythropoietin and anaemia in patients with disseminated bronchial cancer.
Schreuder WO; Ting WC; Smith S; Jacobs A
Br J Haematol; 1984 Jul; 57(3):521-6. PubMed ID: 6430333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
